EASIX predicts non-relapse mortality after haploidentical transplantation with post-transplant cyclophosphamide
Jacopo Mariotti, Filippo Magri, Laura Giordano, Chiara De Philippis, Barbara Sarina, Daniele Mannina, Daniela Taurino, Armando Santoro, Stéfania Bramanti
Topics & Concepts
MedicineInternal medicineHazard ratioCyclophosphamideTransplantationCohortGraft-versus-host diseaseProportional hazards modelRetrospective cohort studySurgeryOncologyGastroenterologyChemotherapyConfidence intervalHematopoietic Stem Cell TransplantationAngiogenesis and VEGF in CancerLymphatic System and Diseases